| Literature DB >> 27563339 |
Longwen Chen1, Kristina A Butler2, Debra A Bell3.
Abstract
Serous borderline tumor (SBT) involving a cervical lymph node is extremely rare. In addition, fine needle aspiration (FNA) cytology of the involved cervical lymph node shares tremendous morphologic similarity with other low-grade papillary carcinomas. Thus, it can be easily misdiagnosed as metastatic carcinoma. A 42-year-old female had a history of bilateral SBT and postbilateral salpingo-oophorectomy. She presented with left cervical lymphadenopathy 6 months later. FNA cytology showed a low-grade papillary neoplasm with psammoma bodies. Needle core biopsy along with immunostains was diagnostic of cervical lymph node involvement (LNI) of SBT. although extremely rare, cervical LNI can be found in patients with SBTs. FNA cytology, sometimes, is indistinguishable from metastatic papillary adenocarcinoma. Cell block or needle core biopsy is essential to make the correct diagnosis.Entities:
Keywords: Cervical lymph node; fine needle aspiration biopsy; ovarian serous borderline tumor
Year: 2016 PMID: 27563339 PMCID: PMC4977969 DOI: 10.4103/1742-6413.187052
Source DB: PubMed Journal: Cytojournal ISSN: 1742-6413 Impact factor: 2.091
Figure 1The Papanicolaou stain cytology smear slide shows numerous papillary groups of epithelioid cells in a background of lymphoid cells (×100)
Figure 2The Papanicolaou stain cytology smear slide shows that the epithelioid cells were relatively uniform. The cells had a high nuclear-to-cytoplasmic ratio. The nuclei were predominantly oval and exhibited fine nuclear chromatin. Quite prominent nuclear grooves and irregular nuclear membrane were also noted (×400)
Figure 3The Papanicolaou stain cytology smear slide shows several psammoma bodies associated with tumor cells (×400)
Figure 4The needle core biopsy shows deposits of tubular and papillary groups of tumor cells with psammomatous calcification in the background of lymphoid tissue (H and E, ×200)
Figure 5The tumor cells are immunoreactive with estrogen receptor (×200)
Figure 6The tumor cells are immunoreactive (nuclear staining) with WT-1 (×200)